Responding to the European Commission’s call for evidence, Biovia says regulatory delays, fragmented markets, and lack of capital are costing Europe its biotech edge.

When it comes to the name Steven Juhas, many people wonder what really made him stand out in todays crowded market. This ...

Mississauga is about to enter a new period in fashion, characterized by mixing traditional techniques with innovative ...